(CHKP) Check Point Software - Overview
Stock: Firewall, CloudGuard, Harmony, ThreatCloud, Infinity
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 25.7% |
| Relative Tail Risk | -6.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.53 |
| Alpha | -27.61 |
| Character TTM | |
|---|---|
| Beta | 0.596 |
| Beta Downside | 0.524 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.44% |
| CAGR/Max DD | 0.49 |
Description: CHKP Check Point Software December 19, 2025
Check Point Software Technologies Ltd. (NASDAQ: CHKP) delivers a layered security portfolio that protects enterprises across cloud, network, mobile, endpoint, and IoT environments. Its flagship offerings include on-premises hyperscale AI-driven threat prevention, the CloudGuard suite for cloud-native security, the Harmony workspace protection platform, and the Infinity platform that unifies prevention, response, and automation with ThreatCloud AI and a generative-AI copilot. The company also provides managed detection and response, incident-response consulting, and professional services to design, implement, and optimize its solutions.
Key data points (FY 2023): revenue of roughly $2.7 billion, with subscription and SaaS revenue representing about 80 % of total and operating margins near 70 %. The cybersecurity market is projected to expand at a 10 % compound annual growth rate through 2029, driven by accelerating cloud migration, rising ransomware incidents, and increasing enterprise adoption of AI-enhanced defenses-trends that directly benefit Check Point’s hyperscale and AI-centric product lines.
For a deeper quantitative assessment, you may want to explore ValueRay’s detailed financial models for CHKP.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.01b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA 2.06 > 1.0 |
| NWC/Revenue: 11.87% < 20% (prev 9.35%; Δ 2.52% < -1%) |
| CFO/TA 0.21 > 3% & CFO 1.21b > Net Income 1.01b |
| Net Debt (-619.9m) to EBITDA (1.00b): -0.62 < 3 |
| Current Ratio: 1.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (109.5m) vs 12m ago -3.44% < -2% |
| Gross Margin: 85.97% > 18% (prev 0.88%; Δ 8509 % > 0.5%) |
| Asset Turnover: 47.88% > 50% (prev 45.80%; Δ 2.08% > 0%) |
| Interest Coverage Ratio: 505.4 > 6 (EBITDA TTM 1.00b / Interest Expense TTM 1.80m) |
Altman Z'' 10.00
| A: 0.06 (Total Current Assets 2.03b - Total Current Liabilities 1.71b) / Total Assets 5.70b |
| B: 2.59 (Retained Earnings 14.77b / Total Assets 5.70b) |
| C: 0.16 (EBIT TTM 909.7m / Avg Total Assets 5.61b) |
| D: 5.65 (Book Value of Equity 14.80b / Total Liabilities 2.62b) |
| Altman-Z'' Score: 15.83 = AAA |
Beneish M -2.98
| DSRI: 1.03 (Receivables 428.4m/391.9m, Revenue 2.68b/2.52b) |
| GMI: 1.02 (GM 85.97% / 87.70%) |
| AQI: 1.00 (AQ_t 0.63 / AQ_t-1 0.63) |
| SGI: 1.06 (Revenue 2.68b / 2.52b) |
| TATA: -0.03 (NI 1.01b - CFO 1.21b) / TA 5.70b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of CHKP shares?
Over the past week, the price has changed by +0.78%, over one month by -2.74%, over three months by -7.94% and over the past year by -14.84%.
Is CHKP a buy, sell or hold?
- StrongBuy: 11
- Buy: 5
- Hold: 22
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CHKP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 222.7 | 23.1% |
| Analysts Target Price | 222.7 | 23.1% |
| ValueRay Target Price | 182.3 | 0.7% |
CHKP Fundamental Data Overview February 03, 2026
P/E Forward = 16.6113
P/S = 7.1795
P/B = 6.212
P/EG = 2.1851
Revenue TTM = 2.68b USD
EBIT TTM = 909.7m USD
EBITDA TTM = 1.00b USD
Long Term Debt = unknown (none)
Short Term Debt = 8.80m USD (from shortTermDebt, last fiscal year)
Debt = 29.8m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -619.9m USD (from netDebt column, last quarter)
Enterprise Value = 17.83b USD (19.27b + Debt 29.8m - CCE 1.47b)
Interest Coverage Ratio = 505.4 (Ebit TTM 909.7m / Interest Expense TTM 1.80m)
EV/FCF = 15.13x (Enterprise Value 17.83b / FCF TTM 1.18b)
FCF Yield = 6.61% (FCF TTM 1.18b / Enterprise Value 17.83b)
FCF Margin = 43.91% (FCF TTM 1.18b / Revenue TTM 2.68b)
Net Margin = 37.62% (Net Income TTM 1.01b / Revenue TTM 2.68b)
Gross Margin = 85.97% ((Revenue TTM 2.68b - Cost of Revenue TTM 376.7m) / Revenue TTM)
Gross Margin QoQ = 85.34% (prev 84.52%)
Tobins Q-Ratio = 3.13 (Enterprise Value 17.83b / Total Assets 5.70b)
Interest Expense / Debt = 6.04% (Interest Expense 1.80m / Debt 29.8m)
Taxrate = 13.00% (126.4m / 972.1m)
NOPAT = 791.4m (EBIT 909.7m * (1 - 13.00%))
Current Ratio = 1.19 (Total Current Assets 2.03b / Total Current Liabilities 1.71b)
Debt / Equity = 0.01 (Debt 29.8m / totalStockholderEquity, last quarter 3.08b)
Debt / EBITDA = -0.62 (Net Debt -619.9m / EBITDA 1.00b)
Debt / FCF = -0.53 (Net Debt -619.9m / FCF TTM 1.18b)
Total Stockholder Equity = 2.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.01% (Net Income 1.01b / Total Assets 5.70b)
RoE = 35.27% (Net Income TTM 1.01b / Total Stockholder Equity 2.86b)
RoCE = 22.82% (EBIT 909.7m / Capital Employed (Total Assets 5.70b - Current Liab 1.71b))
RoIC = 27.64% (NOPAT 791.4m / Invested Capital 2.86b)
WACC = 8.11% (E(19.27b)/V(19.30b) * Re(8.11%) + D(29.8m)/V(19.30b) * Rd(6.04%) * (1-Tc(0.13)))
Discount Rate = 8.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.52%
[DCF Debug] Terminal Value 77.14% ; FCFF base≈1.12b ; Y1≈1.08b ; Y5≈1.06b
Fair Price DCF = 176.7 (EV 18.35b - Net Debt -619.9m = Equity 18.97b / Shares 107.4m; r=8.11% [WACC]; 5y FCF grow -4.96% → 2.90% )
EPS Correlation: -4.84 | EPS CAGR: -43.40% | SUE: -4.0 | # QB: 0
Revenue Correlation: 78.00 | Revenue CAGR: 3.33% | SUE: 2.46 | # QB: 2
EPS next Quarter (2026-03-31): EPS=2.37 | Chg30d=-0.004 | Revisions Net=-3 | Analysts=30
EPS next Year (2026-12-31): EPS=10.49 | Chg30d=-0.066 | Revisions Net=-4 | Growth EPS=-6.9% | Growth Revenue=+6.2%